25 XP   0   0   10

Zhejiang Shouxiangu Pharm Co
Buy, Hold or Sell?

Let's analyse Zhejiang Shouxiangu Pharm Co together

PenkeI guess you are interested in Zhejiang Shouxiangu Pharm Co. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Zhejiang Shouxiangu Pharm Co. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Zhejiang Shouxiangu Pharm Co

I send you an email if I find something interesting about Zhejiang Shouxiangu Pharm Co.

Quick analysis of Zhejiang Shouxiangu Pharm Co (30 sec.)










What can you expect buying and holding a share of Zhejiang Shouxiangu Pharm Co? (30 sec.)

How much money do you get?

How much money do you get?
¥0.17
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥9.44
Expected worth in 1 year
¥15.10
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥6.87
Return On Investment
26.0%

For what price can you sell your share?

Current Price per Share
¥26.44
Expected price per share
¥23.07 - ¥29.64
How sure are you?
50%

1. Valuation of Zhejiang Shouxiangu Pharm Co (5 min.)




Live pricePrice per Share (EOD)

¥26.44

Intrinsic Value Per Share

¥4.76 - ¥10.43

Total Value Per Share

¥14.20 - ¥19.87

2. Growth of Zhejiang Shouxiangu Pharm Co (5 min.)




Is Zhejiang Shouxiangu Pharm Co growing?

Current yearPrevious yearGrowGrow %
How rich?$262.9m$223.5m$39.3m15.0%

How much money is Zhejiang Shouxiangu Pharm Co making?

Current yearPrevious yearGrowGrow %
Making money$38.3m$27.7m$10.6m27.7%
Net Profit Margin33.5%26.2%--

How much money comes from the company's main activities?

3. Financial Health of Zhejiang Shouxiangu Pharm Co (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#196 / 1010

Most Revenue
#92 / 1010

Most Profit
#56 / 1010

Most Efficient
#44 / 1010

What can you expect buying and holding a share of Zhejiang Shouxiangu Pharm Co? (5 min.)

Welcome investor! Zhejiang Shouxiangu Pharm Co's management wants to use your money to grow the business. In return you get a share of Zhejiang Shouxiangu Pharm Co.

What can you expect buying and holding a share of Zhejiang Shouxiangu Pharm Co?

First you should know what it really means to hold a share of Zhejiang Shouxiangu Pharm Co. And how you can make/lose money.

Speculation

The Price per Share of Zhejiang Shouxiangu Pharm Co is ¥26.44. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Zhejiang Shouxiangu Pharm Co.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Zhejiang Shouxiangu Pharm Co, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥9.44. Based on the TTM, the Book Value Change Per Share is ¥1.41 per quarter. Based on the YOY, the Book Value Change Per Share is ¥1.46 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.30 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Zhejiang Shouxiangu Pharm Co.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.190.7%0.190.7%0.140.5%0.120.4%0.070.3%
Usd Book Value Change Per Share0.200.7%0.200.7%0.200.8%0.140.5%0.120.5%
Usd Dividend Per Share0.040.2%0.040.2%0.030.1%0.030.1%0.020.1%
Usd Total Gains Per Share0.240.9%0.240.9%0.230.9%0.170.6%0.150.6%
Usd Price Per Share5.47-5.47-8.00-5.23-3.40-
Price to Earnings Ratio28.82-28.82-58.29-46.54-36.24-
Price-to-Total Gains Ratio23.09-23.09-34.30-31.44-30.45-
Price to Book Ratio4.20-4.20-7.23-5.48-4.06-
Price-to-Total Gains Ratio23.09-23.09-34.30-31.44-30.45-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.64872
Number of shares274
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.040.03
Usd Book Value Change Per Share0.200.14
Usd Total Gains Per Share0.240.17
Gains per Quarter (274 shares)64.9347.04
Gains per Year (274 shares)259.73188.17
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
14621425033155178
29242851066310366
313764277099466554
41838561030132621742
522910701290165776930
6275128415501989311118
73211498181023010871306
83661711207026312421494
94121925233029613971682
104582139259032915521870

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.03.070.0%7.00.04.063.6%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%11.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%11.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%11.00.00.0100.0%

Fundamentals of Zhejiang Shouxiangu Pharm Co

About Zhejiang Shouxiangu Pharm Co

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. researches, develops, and sells Chinese medicine products. It offers ganoderma lucidum spore powder, dendrobium officinale and ganoderma lucidum extract, dendrobium officinale granules, saffron extract, crocus sativus, and other health products. Zhejiang Shouxiangu Pharmaceutical Co., Ltd. was founded in 1997 and is based in Jinhua, China.

Fundamental data was last updated by Penke on 2024-04-18 14:39:07.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is overpriced.

1.1. Profitability of Zhejiang Shouxiangu Pharm Co.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Zhejiang Shouxiangu Pharm Co earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Zhejiang Shouxiangu Pharm Co to the Biotechnology industry mean.
  • A Net Profit Margin of 33.5% means that ¥0.34 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Zhejiang Shouxiangu Pharm Co:

  • The MRQ is 33.5%. The company is making a huge profit. +2
  • The TTM is 33.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ33.5%TTM33.5%0.0%
TTM33.5%YOY26.2%+7.3%
TTM33.5%5Y25.4%+8.1%
5Y25.4%10Y17.7%+7.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ33.5%-207.2%+240.7%
TTM33.5%-216.8%+250.3%
YOY26.2%-282.3%+308.5%
5Y25.4%-436.8%+462.2%
10Y17.7%-597.3%+615.0%
1.1.2. Return on Assets

Shows how efficient Zhejiang Shouxiangu Pharm Co is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Zhejiang Shouxiangu Pharm Co to the Biotechnology industry mean.
  • 9.7% Return on Assets means that Zhejiang Shouxiangu Pharm Co generated ¥0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Zhejiang Shouxiangu Pharm Co:

  • The MRQ is 9.7%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 9.7%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ9.7%TTM9.7%0.0%
TTM9.7%YOY10.2%-0.5%
TTM9.7%5Y9.4%+0.3%
5Y9.4%10Y7.0%+2.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.7%-13.3%+23.0%
TTM9.7%-12.8%+22.5%
YOY10.2%-11.6%+21.8%
5Y9.4%-13.8%+23.2%
10Y7.0%-15.6%+22.6%
1.1.3. Return on Equity

Shows how efficient Zhejiang Shouxiangu Pharm Co is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Zhejiang Shouxiangu Pharm Co to the Biotechnology industry mean.
  • 14.6% Return on Equity means Zhejiang Shouxiangu Pharm Co generated ¥0.15 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Zhejiang Shouxiangu Pharm Co:

  • The MRQ is 14.6%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 14.6%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ14.6%TTM14.6%0.0%
TTM14.6%YOY12.4%+2.2%
TTM14.6%5Y12.0%+2.6%
5Y12.0%10Y8.9%+3.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ14.6%-16.9%+31.5%
TTM14.6%-16.1%+30.7%
YOY12.4%-14.9%+27.3%
5Y12.0%-19.3%+31.3%
10Y8.9%-20.1%+29.0%

1.2. Operating Efficiency of Zhejiang Shouxiangu Pharm Co.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Zhejiang Shouxiangu Pharm Co is operating .

  • Measures how much profit Zhejiang Shouxiangu Pharm Co makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Zhejiang Shouxiangu Pharm Co to the Biotechnology industry mean.
  • An Operating Margin of 28.8% means the company generated ¥0.29  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Zhejiang Shouxiangu Pharm Co:

  • The MRQ is 28.8%. The company is operating very efficient. +2
  • The TTM is 28.8%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ28.8%TTM28.8%0.0%
TTM28.8%YOY24.0%+4.7%
TTM28.8%5Y22.3%+6.4%
5Y22.3%10Y17.5%+4.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ28.8%-298.0%+326.8%
TTM28.8%-238.5%+267.3%
YOY24.0%-288.4%+312.4%
5Y22.3%-486.2%+508.5%
10Y17.5%-628.4%+645.9%
1.2.2. Operating Ratio

Measures how efficient Zhejiang Shouxiangu Pharm Co is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.83 means that the operating costs are ¥0.83 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Zhejiang Shouxiangu Pharm Co:

  • The MRQ is 0.833. The company is less efficient in keeping operating costs low.
  • The TTM is 0.833. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.833TTM0.8330.000
TTM0.833YOY0.904-0.071
TTM0.8335Y0.910-0.077
5Y0.91010Y0.705+0.206
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8333.235-2.402
TTM0.8333.310-2.477
YOY0.9043.838-2.934
5Y0.9105.679-4.769
10Y0.7057.823-7.118

1.3. Liquidity of Zhejiang Shouxiangu Pharm Co.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Zhejiang Shouxiangu Pharm Co is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.90 means the company has ¥3.90 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Zhejiang Shouxiangu Pharm Co:

  • The MRQ is 3.897. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.897. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.897TTM3.8970.000
TTM3.897YOY5.245-1.348
TTM3.8975Y4.316-0.419
5Y4.31610Y3.265+1.051
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.8973.863+0.034
TTM3.8974.169-0.272
YOY5.2455.337-0.092
5Y4.3166.122-1.806
10Y3.2656.434-3.169
1.3.2. Quick Ratio

Measures if Zhejiang Shouxiangu Pharm Co is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Zhejiang Shouxiangu Pharm Co to the Biotechnology industry mean.
  • A Quick Ratio of 0.30 means the company can pay off ¥0.30 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Zhejiang Shouxiangu Pharm Co:

  • The MRQ is 0.301. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.301. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.301TTM0.3010.000
TTM0.301YOY1.076-0.776
TTM0.3015Y0.889-0.588
5Y0.88910Y1.156-0.268
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3013.504-3.203
TTM0.3013.991-3.690
YOY1.0765.371-4.295
5Y0.8896.088-5.199
10Y1.1566.395-5.239

1.4. Solvency of Zhejiang Shouxiangu Pharm Co.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Zhejiang Shouxiangu Pharm Co assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Zhejiang Shouxiangu Pharm Co to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.33 means that Zhejiang Shouxiangu Pharm Co assets are financed with 33.3% credit (debt) and the remaining percentage (100% - 33.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Zhejiang Shouxiangu Pharm Co:

  • The MRQ is 0.333. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.333. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.333TTM0.3330.000
TTM0.333YOY0.174+0.158
TTM0.3335Y0.205+0.128
5Y0.20510Y0.239-0.034
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3330.339-0.006
TTM0.3330.337-0.004
YOY0.1740.271-0.097
5Y0.2050.368-0.163
10Y0.2390.388-0.149
1.4.2. Debt to Equity Ratio

Measures if Zhejiang Shouxiangu Pharm Co is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Zhejiang Shouxiangu Pharm Co to the Biotechnology industry mean.
  • A Debt to Equity ratio of 49.9% means that company has ¥0.50 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Zhejiang Shouxiangu Pharm Co:

  • The MRQ is 0.499. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.499. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.499TTM0.4990.000
TTM0.499YOY0.211+0.287
TTM0.4995Y0.269+0.230
5Y0.26910Y0.339-0.069
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4990.392+0.107
TTM0.4990.403+0.096
YOY0.2110.335-0.124
5Y0.2690.427-0.158
10Y0.3390.461-0.122

2. Market Valuation of Zhejiang Shouxiangu Pharm Co

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Zhejiang Shouxiangu Pharm Co generates.

  • Above 15 is considered overpriced but always compare Zhejiang Shouxiangu Pharm Co to the Biotechnology industry mean.
  • A PE ratio of 28.82 means the investor is paying ¥28.82 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Zhejiang Shouxiangu Pharm Co:

  • The EOD is 19.211. Based on the earnings, the company is fair priced.
  • The MRQ is 28.816. Based on the earnings, the company is overpriced. -1
  • The TTM is 28.816. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD19.211MRQ28.816-9.605
MRQ28.816TTM28.8160.000
TTM28.816YOY58.290-29.474
TTM28.8165Y46.539-17.723
5Y46.53910Y36.236+10.303
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD19.211-2.300+21.511
MRQ28.816-2.656+31.472
TTM28.816-2.718+31.534
YOY58.290-4.145+62.435
5Y46.539-6.258+52.797
10Y36.236-6.315+42.551
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Zhejiang Shouxiangu Pharm Co:

  • The EOD is 33.629. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 50.444. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 50.444. Based on how much money comes from the company's main activities, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD33.629MRQ50.444-16.815
MRQ50.444TTM50.4440.000
TTM50.444YOY86.664-36.221
TTM50.4445Y27.886+22.557
5Y27.88610Y28.466-0.579
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD33.629-2.974+36.603
MRQ50.444-3.306+53.750
TTM50.444-3.508+53.952
YOY86.664-5.613+92.277
5Y27.886-8.378+36.264
10Y28.466-8.873+37.339
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Zhejiang Shouxiangu Pharm Co is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 4.20 means the investor is paying ¥4.20 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Zhejiang Shouxiangu Pharm Co:

  • The EOD is 2.800. Based on the equity, the company is underpriced. +1
  • The MRQ is 4.201. Based on the equity, the company is fair priced.
  • The TTM is 4.201. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.800MRQ4.201-1.400
MRQ4.201TTM4.2010.000
TTM4.201YOY7.226-3.025
TTM4.2015Y5.480-1.279
5Y5.48010Y4.065+1.415
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.8001.914+0.886
MRQ4.2012.116+2.085
TTM4.2012.097+2.104
YOY7.2262.881+4.345
5Y5.4803.550+1.930
10Y4.0653.936+0.129
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Zhejiang Shouxiangu Pharm Co compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.4141.4140%1.455-3%1.026+38%0.876+62%
Book Value Per Share--9.4419.4410%8.027+18%6.946+36%4.610+105%
Current Ratio--3.8973.8970%5.245-26%4.316-10%3.265+19%
Debt To Asset Ratio--0.3330.3330%0.174+91%0.205+62%0.239+39%
Debt To Equity Ratio--0.4990.4990%0.211+136%0.269+85%0.339+47%
Dividend Per Share--0.3030.3030%0.235+29%0.218+39%0.181+67%
Eps--1.3761.3760%0.995+38%0.854+61%0.511+169%
Free Cash Flow Per Share--0.7860.7860%0.669+17%0.535+47%0.296+165%
Free Cash Flow To Equity Per Share--2.4502.4500%0.400+512%0.971+152%0.681+260%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.700+43%
Intrinsic Value_10Y_max--10.425--------
Intrinsic Value_10Y_min--4.760--------
Intrinsic Value_1Y_max--0.856--------
Intrinsic Value_1Y_min--0.345--------
Intrinsic Value_3Y_max--2.715--------
Intrinsic Value_3Y_min--1.158--------
Intrinsic Value_5Y_max--4.748--------
Intrinsic Value_5Y_min--2.096--------
Market Cap5336358548.480-50%8004537822.7208004537822.7200%11706081536.000-32%7648511480.832+5%4976699284.736+61%
Net Profit Margin--0.3350.3350%0.262+28%0.254+32%0.177+89%
Operating Margin--0.2880.2880%0.240+20%0.223+29%0.175+64%
Operating Ratio--0.8330.8330%0.904-8%0.910-8%0.705+18%
Pb Ratio2.800-50%4.2014.2010%7.226-42%5.480-23%4.065+3%
Pe Ratio19.211-50%28.81628.8160%58.290-51%46.539-38%36.236-20%
Price Per Share26.440-50%39.66039.6600%58.000-32%37.896+5%24.658+61%
Price To Free Cash Flow Ratio33.629-50%50.44450.4440%86.664-42%27.886+81%28.466+77%
Price To Total Gains Ratio15.397-50%23.09523.0950%34.303-33%31.437-27%30.450-24%
Quick Ratio--0.3010.3010%1.076-72%0.889-66%1.156-74%
Return On Assets--0.0970.0970%0.102-5%0.094+3%0.070+39%
Return On Equity--0.1460.1460%0.124+18%0.120+22%0.089+64%
Total Gains Per Share--1.7171.7170%1.691+2%1.244+38%1.057+63%
Usd Book Value--262962079.429262962079.4290%223566808.830+18%193450766.860+36%128400094.274+105%
Usd Book Value Change Per Share--0.1950.1950%0.201-3%0.142+38%0.121+62%
Usd Book Value Per Share--1.3031.3030%1.108+18%0.958+36%0.636+105%
Usd Dividend Per Share--0.0420.0420%0.032+29%0.030+39%0.025+67%
Usd Eps--0.1900.1900%0.137+38%0.118+61%0.071+169%
Usd Free Cash Flow--21898237.61121898237.6110%18640211.540+17%14910602.585+47%8254191.690+165%
Usd Free Cash Flow Per Share--0.1080.1080%0.092+17%0.074+47%0.041+165%
Usd Free Cash Flow To Equity Per Share--0.3380.3380%0.055+512%0.134+152%0.094+260%
Usd Market Cap736417479.690-50%1104626219.5351104626219.5350%1615439251.968-32%1055494584.355+5%686784501.294+61%
Usd Price Per Share3.649-50%5.4735.4730%8.004-32%5.230+5%3.403+61%
Usd Profit--38334059.02638334059.0260%27714060.617+38%23787609.937+61%14237841.287+169%
Usd Revenue--114411880.778114411880.7780%105864951.176+8%90816970.545+26%66631978.190+72%
Usd Total Gains Per Share--0.2370.2370%0.233+2%0.172+38%0.146+63%
 EOD+4 -4MRQTTM+0 -0YOY+24 -115Y+28 -710Y+28 -8

3.2. Fundamental Score

Let's check the fundamental score of Zhejiang Shouxiangu Pharm Co based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1519.211
Price to Book Ratio (EOD)Between0-12.800
Net Profit Margin (MRQ)Greater than00.335
Operating Margin (MRQ)Greater than00.288
Quick Ratio (MRQ)Greater than10.301
Current Ratio (MRQ)Greater than13.897
Debt to Asset Ratio (MRQ)Less than10.333
Debt to Equity Ratio (MRQ)Less than10.499
Return on Equity (MRQ)Greater than0.150.146
Return on Assets (MRQ)Greater than0.050.097
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Zhejiang Shouxiangu Pharm Co based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.471
Ma 20Greater thanMa 5025.057
Ma 50Greater thanMa 10026.545
Ma 100Greater thanMa 20028.840
OpenGreater thanClose26.000
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets2,856,190
Total Liabilities950,667
Total Stockholder Equity1,905,522
 As reported
Total Liabilities 950,667
Total Stockholder Equity+ 1,905,522
Total Assets = 2,856,190

Assets

Total Assets2,856,190
Total Current Assets1,862,011
Long-term Assets994,178
Total Current Assets
Cash And Cash Equivalents 1,524,712
Short-term Investments 30,000
Net Receivables 113,660
Inventory 147,756
Other Current Assets 19,354
Total Current Assets  (as reported)1,862,011
Total Current Assets  (calculated)1,835,483
+/- 26,529
Long-term Assets
Property Plant Equipment 570,966
Intangible Assets 78,158
Other Assets 251,078
Long-term Assets  (as reported)994,178
Long-term Assets  (calculated)900,202
+/- 93,976

Liabilities & Shareholders' Equity

Total Current Liabilities477,765
Long-term Liabilities472,902
Total Stockholder Equity1,905,522
Total Current Liabilities
Short Long Term Debt 272,972
Accounts payable 103,976
Other Current Liabilities 24,799
Total Current Liabilities  (as reported)477,765
Total Current Liabilities  (calculated)401,747
+/- 76,018
Long-term Liabilities
Long term Debt 412,589
Capital Lease Obligations Min Short Term Debt15,971
Other Liabilities 44,342
Deferred Long Term Liability 53,135
Long-term Liabilities  (as reported)472,902
Long-term Liabilities  (calculated)526,037
+/- 53,135
Total Stockholder Equity
Common Stock197,203
Retained Earnings 908,452
Other Stockholders Equity 108,727
Total Stockholder Equity (as reported)1,905,522
Total Stockholder Equity (calculated)1,214,382
+/- 691,140
Other
Capital Stock197,203
Common Stock Shares Outstanding 197,203
Net Invested Capital 2,591,084
Net Tangible Assets 1,827,365
Net Working Capital 1,384,246
Property Plant and Equipment Gross 570,966



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
> Total Assets 
274,006
409,353
500,992
605,908
612,095
926,344
1,191,527
1,340,784
1,699,583
1,962,460
2,856,190
2,856,1901,962,4601,699,5831,340,7841,191,527926,344612,095605,908500,992409,353274,006
   > Total Current Assets 
0
0
0
0
166,858
483,559
532,021
602,968
922,803
1,045,299
1,862,011
1,862,0111,045,299922,803602,968532,021483,559166,8580000
       Cash And Cash Equivalents 
48,155
77,130
40,899
18,238
4,675
89,191
166,024
205,624
669,248
677,984
1,524,712
1,524,712677,984669,248205,624166,02489,1914,67518,23840,89977,13048,155
       Short-term Investments 
0
0
0
15,500
10,666
218,000
31,223
198,500
50,000
130,000
30,000
30,000130,00050,000198,50031,223218,00010,66615,500000
       Net Receivables 
31,764
91,749
37,818
39,484
39,838
39,051
66,374
70,713
70,072
84,521
113,660
113,66084,52170,07270,71366,37439,05139,83839,48437,81891,74931,764
       Other Current Assets 
8,602
8,304
5,974
7,447
10,558
24,615
181,006
18,036
19,851
17,644
19,354
19,35417,64419,85118,036181,00624,61510,5587,4475,9748,3048,602
   > Long-term Assets 
0
0
0
0
445,237
442,786
659,506
737,816
776,780
917,161
994,178
994,178917,161776,780737,816659,506442,786445,2370000
       Property Plant Equipment 
86,994
126,209
186,705
238,572
232,284
172,811
268,073
288,865
354,709
493,498
570,966
570,966493,498354,709288,865268,073172,811232,284238,572186,705126,20986,994
       Intangible Assets 
3,541
3,593
3,577
61,709
76,711
77,504
74,259
80,843
78,577
82,978
78,158
78,15882,97878,57780,84374,25977,50476,71161,7093,5773,5933,541
       Long-term Assets Other 
0
0
0
0
3,345
4,479
7,183
5,506
1,045
7,298
3,563
3,5637,2981,0455,5067,1834,4793,3450000
> Total Liabilities 
135,637
109,853
180,427
237,378
175,169
56,596
206,788
168,315
373,277
342,410
950,667
950,667342,410373,277168,315206,78856,596175,169237,378180,427109,853135,637
   > Total Current Liabilities 
115,087
91,463
171,933
225,747
165,365
48,055
195,771
146,451
164,694
199,276
477,765
477,765199,276164,694146,451195,77148,055165,365225,747171,93391,463115,087
       Short-term Debt 
0
0
0
0
123,000
0
40,000
10,000
0
0
0
00010,00040,0000123,0000000
       Short Long Term Debt 
0
0
0
0
123,000
0
40,000
10,000
0
0
272,972
272,9720010,00040,0000123,0000000
       Accounts payable 
31,234
27,888
45,310
21,554
12,440
16,955
23,318
17,189
56,612
107,936
103,976
103,976107,93656,61217,18923,31816,95512,44021,55445,31027,88831,234
       Other Current Liabilities 
47,853
20,075
22,623
36,593
11,576
13,012
99,156
84,797
53,834
31,673
24,799
24,79931,67353,83484,79799,15613,01211,57636,59322,62320,07547,853
   > Long-term Liabilities 
0
0
0
0
9,804
8,541
11,017
21,864
208,582
143,134
472,902
472,902143,134208,58221,86411,0178,5419,8040000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
-123,000
0
-40,000
-10,000
12,792
13,330
15,971
15,97113,33012,792-10,000-40,0000-123,0000000
       Deferred Long Term Liability 
0
0
0
0
21,154
17,730
21,411
28,512
27,730
39,931
53,135
53,13539,93127,73028,51221,41117,73021,1540000
> Total Stockholder Equity
138,369
299,500
320,565
368,530
436,926
869,748
984,738
1,172,470
1,326,306
1,619,665
1,905,522
1,905,5221,619,6651,326,3061,172,470984,738869,748436,926368,530320,565299,500138,369
   Common Stock
56,500
104,850
104,850
104,850
104,850
139,800
143,335
143,872
148,011
152,498
197,203
197,203152,498148,011143,872143,335139,800104,850104,850104,850104,85056,500
   Retained Earnings 
28,411
54,360
75,425
123,390
191,786
263,889
342,875
433,705
536,046
690,986
908,452
908,452690,986536,046433,705342,875263,889191,786123,39075,42554,36028,411
   Capital Surplus 00000000000
   Treasury Stock00000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
29,935
67,556
41,062
108,727
108,72741,06267,55629,9350000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue864,059
Cost of Revenue-147,249
Gross Profit716,810716,810
 
Operating Income (+$)
Gross Profit716,810
Operating Expense-589,370
Operating Income274,689127,440
 
Operating Expense (+$)
Research Development49,731
Selling General Administrative361,418
Selling And Marketing Expenses-
Operating Expense589,370411,149
 
Net Interest Income (+$)
Interest Income8,287
Interest Expense-31,980
Other Finance Cost-33,995
Net Interest Income10,302
 
Pretax Income (+$)
Operating Income274,689
Net Interest Income10,302
Other Non-Operating Income Expenses-
Income Before Tax (EBT)287,007274,689
EBIT - interestExpense = -31,980
287,008
318,988
Interest Expense31,980
Earnings Before Interest and Taxes (EBIT)-318,987
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax287,007
Tax Provision-273
Net Income From Continuing Ops286,734286,734
Net Income287,008
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--10,302
 

Technical Analysis of Zhejiang Shouxiangu Pharm Co
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Zhejiang Shouxiangu Pharm Co. The general trend of Zhejiang Shouxiangu Pharm Co is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Zhejiang Shouxiangu Pharm Co's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Zhejiang Shouxiangu Pharm Co.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 26.64 < 29.06 < 29.64.

The bearish price targets are: 25.76 > 23.49 > 23.07.

Tweet this
Zhejiang Shouxiangu Pharm Co Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Zhejiang Shouxiangu Pharm Co. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Zhejiang Shouxiangu Pharm Co Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Zhejiang Shouxiangu Pharm Co. The current macd is -0.28921243.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Zhejiang Shouxiangu Pharm Co price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Zhejiang Shouxiangu Pharm Co. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Zhejiang Shouxiangu Pharm Co price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Zhejiang Shouxiangu Pharm Co Daily Moving Average Convergence/Divergence (MACD) ChartZhejiang Shouxiangu Pharm Co Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Zhejiang Shouxiangu Pharm Co. The current adx is 17.51.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Zhejiang Shouxiangu Pharm Co shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Zhejiang Shouxiangu Pharm Co Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Zhejiang Shouxiangu Pharm Co. The current sar is 23.84.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Zhejiang Shouxiangu Pharm Co Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Zhejiang Shouxiangu Pharm Co. The current rsi is 56.47. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Zhejiang Shouxiangu Pharm Co Daily Relative Strength Index (RSI) ChartZhejiang Shouxiangu Pharm Co Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Zhejiang Shouxiangu Pharm Co. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Zhejiang Shouxiangu Pharm Co price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Zhejiang Shouxiangu Pharm Co Daily Stochastic Oscillator ChartZhejiang Shouxiangu Pharm Co Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Zhejiang Shouxiangu Pharm Co. The current cci is 187.76.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Zhejiang Shouxiangu Pharm Co Daily Commodity Channel Index (CCI) ChartZhejiang Shouxiangu Pharm Co Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Zhejiang Shouxiangu Pharm Co. The current cmo is 27.01.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Zhejiang Shouxiangu Pharm Co Daily Chande Momentum Oscillator (CMO) ChartZhejiang Shouxiangu Pharm Co Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Zhejiang Shouxiangu Pharm Co. The current willr is -15.47277937.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Zhejiang Shouxiangu Pharm Co Daily Williams %R ChartZhejiang Shouxiangu Pharm Co Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Zhejiang Shouxiangu Pharm Co.

Zhejiang Shouxiangu Pharm Co Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Zhejiang Shouxiangu Pharm Co. The current atr is 0.890905.

Zhejiang Shouxiangu Pharm Co Daily Average True Range (ATR) ChartZhejiang Shouxiangu Pharm Co Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Zhejiang Shouxiangu Pharm Co. The current obv is 4,161,564.

Zhejiang Shouxiangu Pharm Co Daily On-Balance Volume (OBV) ChartZhejiang Shouxiangu Pharm Co Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Zhejiang Shouxiangu Pharm Co. The current mfi is 62.66.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Zhejiang Shouxiangu Pharm Co Daily Money Flow Index (MFI) ChartZhejiang Shouxiangu Pharm Co Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Zhejiang Shouxiangu Pharm Co.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-05BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-06ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-07ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-11MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-26MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-22BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-23CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Zhejiang Shouxiangu Pharm Co Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Zhejiang Shouxiangu Pharm Co based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.471
Ma 20Greater thanMa 5025.057
Ma 50Greater thanMa 10026.545
Ma 100Greater thanMa 20028.840
OpenGreater thanClose26.000
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Zhejiang Shouxiangu Pharm Co with someone you think should read this too:
  • Are you bullish or bearish on Zhejiang Shouxiangu Pharm Co? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Zhejiang Shouxiangu Pharm Co? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Zhejiang Shouxiangu Pharm Co

I send you an email if I find something interesting about Zhejiang Shouxiangu Pharm Co.


Comments

How you think about this?

Leave a comment

Stay informed about Zhejiang Shouxiangu Pharm Co.

Receive notifications about Zhejiang Shouxiangu Pharm Co in your mailbox!